WebMay 6, 2024 · BOSTON-- (BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that its Board of Directors has authorized a new share repurchase program under which the Company may repurchase up to $150 million of its outstanding shares of common stock through December 2024. WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI …
Ironwood Pharmaceuticals - Overview, News & Competitors
WebApr 14, 2024 · Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. The business had revenue of $107.20 million during the quarter, compared to analyst estimates of $108.23... WebIronwood Pharmaceuticals to Participate in Upcoming Investor Conferences BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that management will participate in the following investor conferences: Cowen 43rd Annual Health Care Conference on Monday, March 6, 2024 at … i miss you by incubus lyrics
Everence Capital Management Inc. Has $558,000 Stock Holdings …
WebApr 12, 2024 · Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)’s beta value is currently sitting at 0.95, while the Average True Range indicator is currently displaying 0.29. With analysts defining $9.00-$16.00 as the low and high price targets, we arrive at a consensus price target of $12.75 for the trailing 12-month period. WebSep 6, 2024 · BOSTON, Mass., September 06, 2024 -- ( BUSINESS WIRE )-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced positive topline data from a Phase III clinical trial evaluating LINZESS... WebJan 4, 2024 · Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and … i miss you by incubus